StonvexLoading…
StonvexStonvexStonvexCore line items from SLNH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $29.72M | $38.02M |
Operating Income | $-33.68M | $-47.52M |
Net Income | $-53.41M | $-63.33M |
EPS (Diluted) | $-2.38 | $-14.94 |
Total Assets | $187.94M | $88.04M |
Total Liabilities | $75.70M | $60.68M |
Cash & Equivalents | $76.42M | $7.84M |
Free Cash Flow OCF − CapEx | $-37.21M | $-13.92M |
Shares Outstanding | 102.53M | 10.61M |